# Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction

> **NCT05098457** · NA · WITHDRAWN · sponsor: **Galderma R&D**

## Conditions studied

- Cheek Wrinkles
- Midface Contour Deficiencies

## Interventions

- **DEVICE:** GP0112
- **DEVICE:** Restylane Lyft Lidocaine

## Key facts

- **NCT ID:** NCT05098457
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-22
- **Primary completion:** 2023-02-19
- **Final completion:** 2023-11-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05098457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05098457, "Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05098457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*